Israel: A Quality Destination for Clinical Research
The global clinical trials market is projected to reach $101.5bn by 2030. Within that growth, Israel is playing an increasingly important role.
In our latest podcast with GlobalData, Oximio’s Chief Commercial Officer, Zayheda Khan, and Israel Pharmacist QP & Warehouse Management expert, Stanislav Liakhovski, explore what makes the country such an attractive destination for clinical research and clinical trial logistics.
The discussion explores:
- Why Israel continues to attract global pharmaceutical and biotech sponsors
- The advantages of Israel’s healthcare system and patient population
- Key therapeutic areas driving research activity
- How streamlined regulatory pathways accelerate study start-up times
- The growing role of AI and innovation in shaping the future of clinical trials
- The critical importance of agile, resilient logistics operations in complex environments
The conversation also offers valuable behind-the-scenes insight into the realities of managing clinical trial supply chains in one of the world’s most dynamic healthcare and innovation ecosystems.
A must-listen for sponsors, CROs, biotech companies, and anyone involved in global clinical research.
To find out how we can support your clinical trial in Israel, explore our supply chain solutions.
